Official communication about our medicines
containing semaglutide from Novo Nordisk
This site is intended for a US audience
Why counterfeit "semaglutide" is a concern
Counterfeit "semaglutide" is illegal and may look like authentic medication but could contain no semaglutide at all, the wrong ingredients, or incorrect amount of alleged semaglutide. In one case, a counterfeit pen contained insulin. Also concerning is that counterfeit product may include harmful substances.2
This means the medication may not work effectively, may cause serious health problems or in some cases may be life-threatening.1
For anyone considering medicines containing semaglutide, taking steps to acquire genuine, FDA-approved (U.S. Food and Drug Administration) medication is essential for protecting one’s health.
Tips to help identify authentic FDA-approved medicines containing semaglutide
- Talk to Your Doctor: Your doctor can provide a valid prescription for FDA-approved medicines containing semaglutide and guide you on where to fill it.
- Check with your insurance: Some insurance providers have lists of approved pharmacies where you can get FDA-approved medications. This can make it easier to find a legitimate source for medicines containing semaglutide.
- Use a reliable state-licensed retail pharmacy: Getting your medicines from a reputable and well-established pharmacy will help as the FDA recommends retail pharmacies purchase through authorized distributors of Novo Nordisk.
- Some insurance providers have lists of approved pharmacies where you can get FDA-approved medications.
- Inspect the medication: The FDA recommends that you ask yourself, “Does the drug or packaging look different than what you normally receive?”
What to do if you spot counterfeit "semaglutide"
If you think you've come across counterfeit semaglutide, here's what to do:
- Talk to your doctor: If you think you are taking a counterfeit product, you should immediately discontinue use and contact your healthcare provider.
- Report side effects: You are encouraged to report the side effects to FDA's MedWatch Safety Information and Adverse Event Reporting Program (1-800-FDA-1088 or www.fda.gov/medwatch) as well as to Novo Nordisk Customer Care number (1-800-727-6500).
- Learn more from the FDA: Considering an online pharmacy? The FDA’s BeSafeRx website includes educational materials and information on reporting unlawful sales of medical products on the internet.
Click below to download a summary guide of this article.
Click below to download a summary guide of this article.
Additional information
Links to additional information can be found in the Patient Safety section of this website, semaglutide.com, including instructions for patients who were affected by a previous discovery of counterfeit semaglutide medicine identified in the U.S.
References:
- FDA’s concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration. Published 2024. https://www.fda.gov/drugs/ postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- Hach M, Dorthe Kot Engelund, Mysling S, et al. Impact of manufacturing process and compounding on properties and quality of follow-on glp-1 polypeptide drugs. Pharmaceutical Research. Published online October 8, 2024. 10.1007/ s11095-024-03771-6